Vaccines
24 April 2017
Inovio Initiates Phase 2 Efficacy Trial with VGX-3100 For HPV-Related Vulvar Pre-Cancers20 April 2017
Targovax initiates first clinical trial with TG02, the second product from its RAS-peptide immunotherapy platform19 April 2017
Argos Reports Interim Results of the ADAPT Trial and Provides Perspective on Decision to Continue the Trial17 April 2017
ACARIZAX® approved in Europe for use in adolescent patients with house dust mite-induced allergic rhinitis11 April 2017
Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable Safety Profile in Expanded Clinical Trial11 April 2017
Zika virus: Themis Bioscience initiates worldwide first study with live attenuated recombinant vaccine28 March 2017
CureLab Oncology, Inc. Publishes Results of Phase I/IIa Clinical Trials of Its Anti-Cancer DNA Vaccine, ElenagenNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports